Restart TICrH AP Pilot Trial

Traumatic Intracranial Hemorrhage Clinical Trial

Official title:
A Prospective Randomized Open-Label Blinded Endpoint (PROBE) Pilot Trial of Early Restarting Antiplatelet Therapy Versus Usual Care After Traumatic Intracranial Hemorrhage.

Status Not yet recruiting

Clinical Trial Summary

A Prospective Randomized Open-Label Blinded Endpoint (PROBE) Pilot Trial of restarting antiplatelet therapy at 1 week versus 3 weeks after traumatic intracranial hemorrhage with a primary composite endpoint of major bleeding and vascular occlusive events.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hemorrhage
Intracranial Hemorrhage, Traumatic
Intracranial Hemorrhages
Traumatic Intracranial Hemorrhage

Clinical Trial Details

NCT number	NCT05000060
Study type	Interventional
Source	University of Texas at Austin
Contact	Truman J Milling, MD
Phone	15124969742
Email	tjmilling@yahoo.com
Status	Not yet recruiting
Phase	Phase 3
Start date	October 1, 2022
Completion date	October 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05609734` - No Cases of Delayed Intracranial Hemorrhage (d-ICH) Among Patients With Mild Traumatic Brain Injury (mTBI) on Oral Anticoagulation Therapy
Completed	`NCT05609721` - Mild Traumatic Brain Injury and the Risk for Traumatic Intracranial Hemorrhage
Enrolling by invitation	`NCT06433622` - Platelet Transfusion and Repeat TEG-PM in Patients With Severe TBI on Antiplatelet Therapy (Repeat TEG-PM)
Completed	`NCT02728908` - Detecting Traumatic Intracranial Hemorrhage With Microwave Technology	N/A